Category: ‘Clinical Trials and Studies’
New Trial Gives Hope To People With Spinal Cord Injuries In Australia
Posted on April 13th, 2023
Doctors say they’re on the cusp of offering the chance to return function to people living with spinal cord injuries, and the treatment will soon be available in Australia.
Read more of New Trial Gives Hope To People With Spinal Cord Injuries In Australia »
Orthocell Delivers Outstanding Results in Remplir™ Nerve Regeneration Trial
Posted on June 7th, 2022
Read more of Orthocell Delivers Outstanding Results in Remplir™ Nerve Regeneration Trial »
Keio University Uses iPS Cells in First Treatment of Spinal Cord Injury
Posted on January 15th, 2022
Keio University in Tokyo said Friday it has started the world’s first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries.
In the study commenced in December, the university will eventually transplant cells derived from iPS cells to four patients who between two to four weeks earlier lost motor and sensory function after sustaining injuries when playing sport or in traffic accidents.
Read more of Keio University Uses iPS Cells in First Treatment of Spinal Cord Injury »
Israeli Biotech Company, Matricelf, Paves a New Way in Healing Injured Spinal Cords
Posted on January 12th, 2022
The company successfully used human implants for replacing the injured spinal cord of a living pig, thereby simulating the anticipated surgical procedure in humans.
Spinal cord injuries are notoriously difficult to operate on, but an Israeli biotech company has entered a new road on the way to a cure using pigs.
Read more of Israeli Biotech Company, Matricelf, Paves a New Way in Healing Injured Spinal Cords »
Neuroplast Announces Successful Clinical Phase I Trial with Neuro-Cells Stem Cell Treatment for Traumatic Spinal Cord Injury
Posted on November 11th, 2021
Dutch biotech company, Neuroplast, and the Hospital Nacional de Parapléjicos de Toledo in Spain have announced positive clinical Phase I results after analysis of ten patients suffering from traumatic spinal cord injury (TSCI), with data demonstrating that its investigational stem cell treatment, Neuro-Cells, appears to be safe and well tolerated, without product-related adverse events.
The treatment uses the patient’s own stem cells to prevent further loss of function after sustaining TSCI, in an effort to limit loss of mobility and independence of otherwise life-long impairment.